Cancer Trials Ireland
- Country
- 🇮🇪Ireland
- Ownership
- Private
- Established
- 1996-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.cancertrials.ie
TC Avastin. ICORG 08-10, V6
- Conditions
- Interventions
- First Posted Date
- 2009-06-02
- Last Posted Date
- 2019-08-01
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 106
- Registration Number
- NCT00911716
- Locations
- 🇮🇪
Cancer Trials Ireland Investigative Site, Waterford, Ireland
🇩🇰Dept. of Oncology; Rigshospitalet, Blegdamsvej, Copenhagen, Denmark
PAD. ICORG 05-01, V11
- Conditions
- Interventions
- First Posted Date
- 2008-12-25
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 53
- Registration Number
- NCT00814541
- Locations
- 🇮🇪
Mater Misericordiae University Hospital, Dublin, Ireland
🇬🇧Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
🇮🇪Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital, Dublin, Ireland
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
- Conditions
- Interventions
- Biological: pegfilgrastimBiological: rituximabDrug: cyclophosphamideDrug: fludarabine phosphateGenetic: cytogenetic analysisGenetic: fluorescence in situ hybridizationGenetic: gene expression analysisGenetic: mutation analysisGenetic: protein expression analysisOther: flow cytometryOther: laboratory biomarker analysis
- First Posted Date
- 2008-12-22
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 52
- Registration Number
- NCT00812669
- Locations
- 🇮🇪
St. James's Hospital, Dublin, Ireland
🇮🇪University College Hospital, Galway, Ireland
🇮🇪Waterford Regional Hospital, Waterford, Ireland
Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
- Conditions
- Interventions
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 40
- Registration Number
- NCT00809211
- Locations
- 🇩🇪
Universitätsklinikum Charité Berlin, Berlin, Germany
🇮🇪St. James's Hospital, Dublin, Ireland
🇮🇪University College Hospital, Galway, Ireland
3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 6
- Registration Number
- NCT00802711
- Locations
- 🇮🇪
Saint Luke's Radiation Oncology Network, Dublin, Ireland
Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma
- Conditions
- Interventions
- First Posted Date
- 2008-09-19
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 32
- Registration Number
- NCT00755976
- Locations
- 🇮🇪
Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital, Dublin, Ireland
🇮🇪Cork University Hospital, Cork, Ireland
🇮🇪Mater Misericordiae University Hospital, Dublin, Ireland
Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30
- First Posted Date
- 2008-09-16
- Last Posted Date
- 2016-02-15
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 10
- Registration Number
- NCT00753207
- Locations
- 🇮🇪
St Vincent's University Hospital, Dublin, Ireland
🇮🇪The Adelaide and Meath Hospital, Dublin Incorporating the National Childresn's Hospital, Dublin, Ireland
🇮🇪St James's Hospital, Dublin, Ireland
Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
- Conditions
- Interventions
- First Posted Date
- 2007-08-09
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 33
- Registration Number
- NCT00513877
- Locations
- 🇮🇪
Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital, Dublin, Ireland
🇧🇪Universitair Ziekenhuis Gent, Ghent, Belgium
🇮🇪Cork University Hospital, Cork, Ireland